Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.38 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.38 |
| ▸ | CRHBP | P24387 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.38 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14744143 | 1.00 | MEN1 (0.46) | MEN1KMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL14746322 | 0.93 | ESR1 (0.43) | MEN1KMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL14746323 | 0.93 | ESR1 (0.43) | MEN1KMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL15494352 | 0.91 | MEN1 (0.40) | MEN1KMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL8722337 | 0.90 | MEN1 (0.59) | MEN1KMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL14029172 | 0.89 | CES2 (0.43) | MEN1KMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL16760716 | 0.89 | ESR1 (0.50) | MEN1KMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL21299097 | 0.87 | EGFR (0.42) | MEN1KMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL19797941 | 0.87 | MEN1 (0.37) | MEN1KMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL15494367 | 0.84 | KMT2A (0.39) | MEN1KMT2AMAPTALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017176216-A1 | A MULTIMODAL FLUORESCENT PROBE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-10-12 | — | — | WO | claimed |
| US-10753941-B2 | Biocompatible nanoparticles with aggregation induced emission characteristics as fluorescent bioprobes and methods of using the same for in vitro and in vivo imaging | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2020-08-25 | — | — | US | disclosed |
| WO-2017176216-A1 | A MULTIMODAL FLUORESCENT PROBE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-10-12 | — | — | WO | disclosed |
| WO-2017176216-A1 | A MULTIMODAL FLUORESCENT PROBE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-10-12 | — | — | WO | disclosed |
| US-20140328764-A1 | Biocompatible Nanoparticles with Aggregation Induced Emission Characteristics as Fluorescent Bioprobes and Methods of Using the Same for In Vitro and In Vivo Imaging | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2014-11-06 | — | — | US | disclosed |
| WO-2013029340-A9 | BIOCOMPATIBLE NANOPARTICLES WITH AGGREGATION INDUCED EMISSION CHARACTERISTICS AS FLUORESCENT BIOPROBES AND METHODS OF USING THE SAME FOR IN VITRO AND IN VIVO IMAGING | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2013-07-11 | — | — | WO | disclosed |
| WO-2013029340-A1 | BIOCOMPATIBLE NANOPARTICLES WITH AGGREGATION INDUCED EMISSION CHARACTERISTICS AS FLUORESCENT BIOPROBES AND METHODS OF USING THE SAME FOR IN VITRO AND IN VIVO IMAGING | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2013-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10753941-B2 | Biocompatible nanoparticles with aggregation induced emission characteristics as fluorescent bioprobes and methods of using the same for in vitro and in vivo imaging | LGALS3, LGALS1, CD63 | MEN1 1917/4885KMT2A 4428/4885MAPT 726/4885 |
| US-20140328764-A1 | Biocompatible Nanoparticles with Aggregation Induced Emission Characteristics as Fluorescent Bioprobes and Methods of Using the Same for In Vitro and In Vivo Imaging | LGALS3, LGALS1, CD63 | MEN1 1917/4885KMT2A 4428/4885MAPT 726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.